Ya-Jing Fu
Overview
Explore the profile of Ya-Jing Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu M, Liu J, Wang P, Fu Y, Zhao M, Jiang Y, et al.
Arch Pathol Lab Med
. 2024 Feb;
148(11):1234-1243.
PMID: 38385871
Context.—: Regulatory T-cell (Treg) detection in peripheral blood, based on flow cytometry, is invaluable for diagnosis and treatment of immune-mediated diseases. However, there is a lack of reliable methods to...
2.
Li S, Yin L, Ding H, Liu M, Lv J, Li J, et al.
Front Immunol
. 2023 Mar;
14:1106881.
PMID: 36875092
The complex mechanism of immune-system damage in HIV infection is incompletely understood. HIV-infected "rapid progressors" (RPs) have severe damage to the immune system early in HIV infection, which provides a...
3.
Li X, Liu M, Fu Y, Jiang Y, Zhang Z
Cytokine
. 2022 Oct;
161:156056.
PMID: 36240721
Background: The mortality rate of patients with sepsis has been increasing in recent years. Alterations of biomarkers levels during treatment are important in evaluating treatment efficacy and predicting outcomes in...
4.
Cai H, Shi J, Yin L, Zheng J, Fu Y, Jiang Y, et al.
Front Microbiol
. 2022 Jul;
13:880873.
PMID: 35875558
Background: Despite the benefits of antiretroviral therapy (ART) for people with HIV, T-cell dysfunction cannot be fully restored. Metabolic dysregulation is associated with dysfunction of HIV-1-specific T-cells. Exploration of the...
5.
Lv J, Li J, Cui Y, Ren Y, Fu Y, Jiang Y, et al.
Front Immunol
. 2021 Dec;
12:753044.
PMID: 34887859
Background: Approximately 10-40% of people with human immunodeficiency virus (HIV) infection are unable to obtain successful improvements in immune function after antiretroviral therapy (ART). These patients are at greater risk...
6.
Xu J, Han M, Jiang Y, Ding H, Li X, Han X, et al.
Chin Med J (Engl)
. 2021 Nov;
134(23):2799-2809.
PMID: 34759226
In the past 37 years, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) has undergone various major transmission routes in China, with the world most complex co-circulating HIV-1 subtypes, even the prevalence...
7.
Wu X, Li Y, Song C, Chen Y, Fu Y, Jiang Y, et al.
Front Immunol
. 2020 Mar;
11:88.
PMID: 32132992
[This corrects the article DOI: 10.3389/fimmu.2018.02850.].
8.
Li S, Zhang Z, Jiang Y, Fu Y, Shang H
J Transl Med
. 2020 Feb;
18(1):96.
PMID: 32093694
Background: Disease progression in the absence of therapy varies significantly in mono-HIV and HCV infected individuals. Virus-specific CD8 T cells play an important role in restricting lentiviral replication and determining...
9.
Song C, Zhang L, Wu X, Fu Y, Jiang Y, Shang H, et al.
J Transl Med
. 2020 Feb;
18(1):95.
PMID: 32093678
Background: Despite the effective antiretroviral treatment (ART) of HIV-infected individuals, HIV persists in a small pool. Central memory CD4 T cells (Tcm) make a major contribution to HIV persistence. We...
10.
Ding Z, Zheng J, Song C, Fu Y, Xu J, Jiang Y, et al.
Cytokine
. 2019 Aug;
125:154801.
PMID: 31442680
Background: HIV rapid progressors (RPs) present with a rapid decline of CD4 T cells within a few years of infection. Determining the underlying mechanisms throughout this decline is important to...